Insights
Keep up with the latest news, insights and events from Norstella and its market-leading brands
- Article
Wall Street Journal spotlights Norstella in post-pandemic vaccines feature
Norstella recently spoke with the Wall Street Journal’s Brian Gormley in a feature article: Biotech VC’s Vaccine Die-Hards. The piece explores how investment has pivoted away from vaccines, leaving a select group of committed developers to carry the flag. Strides made during the pandemic mean…
- Article
From fuel to firepower: How real-world data and AI are accelerating pharma
Real-world data (RWD) and Artificial Intelligence (AI) are evolving fast, and with the integration of unstructured data, large language models (LLMs), and multimodal data sources, the next generation of RWD promises deeper, more holistic patient insights than ever before. By combining clinical notes, patient-reported outcomes,…
- Article
Norstella and Replit team up to accelerate innovation and optimize commercial processes with AI
Innovation at Norstella often begins with a question: What if we could move faster—without sacrificing quality or compliance? During a recent hackathon, Norstella’s commercial and product teams had a chance to answer that question firsthand and help us drive our mission of improving patient access…
- Article
The convergence of AI and real-world data are reshaping clinical trials
As clinical trials increase in number and complexity, so does the competition for the patients best aligned to the study requirements. And with clinical trial processes relatively unchanged over the past decades, a patient and investigator bottleneck has emerged. Finally, with the convergence of artificial…
Work with us
Join our mission
We’re looking for agile, growth-oriented team players who are passionate about client success and helping clients bring life-saving therapies to market quicker—and help patients in need.
Get in touch
Let's connect
Have questions about Norstella or its brands? Or do you want to know more about how to solve your challenges at each stage of the drug life cycle?